Newsroom

NEW YORK--(BUSINESS WIRE)--Surgery Partners, Inc. is being Investigated after the $23.50 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law...

GAFFNEY, S.C.--(BUSINESS WIRE)--First Solar, Inc. (Nasdaq: FSLR) ("First Solar" or "the Company") will inaugurate the first phase of its new facility in Gaffney, Cherokee County, South Carolina, on Wednesday, October 28, 2026.South Carolina Governor Henry McMaster, US Senator Darline Graham, US Secretary of Commerce Howard Lutnick, State Senator Harvey Peeler, State Representatives Dennis Moss and Brian Lawson, and Gaffney Mayor Lyman D. Dawkins III are expected to join First Solar Chief Executi...

SAO PAULO--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) brachte heute ein Rechtsgutachten in Umlauf, das von AHF Brasil und Third World Network (TWN) vorgelegt und von 11 Rechtsexperten unterzeichnet wurde. Es kommt zu dem Schluss, dass das „hybride Modell", das für den Anhang von World Health Organization Pandemic Agreement’s Pathogen Access and Benefit-Sharing (PABS) zur Diskussion steht, nicht vereinbar ist mit dem, was die Länder bereits vereinbart haben. Hintergrund Während der COVID-...

SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) announced today that it intends to report its financial results for the third quarter ended September 30, 2026, on Tuesday, November 3, 2026, after the stock market closes. Management will host a call on Wednesday, November 4, 2026, at 11:30 a.m. ET to discuss the financial results and related information. PACS Group invites current and prospective investors to listen to the call via webcast by going to the...

NEW YORK--(BUSINESS WIRE)--JPMorgan Chase & Co. (NYSE: JPM) (“JPMorganChase” or the “Firm”) plans to host conference calls to review financial results on the following dates: First-quarter 2027 – Tuesday, April 13, 2027 at 8:30 a.m. (Eastern) (previously announced) Second-quarter 2027 – Tuesday, July 13, 2027 at 8:30 a.m. (Eastern) (previously announced) Third-quarter 2027 – Tuesday, October 12, 2027 at 8:30 a.m. (Eastern) (previously announced) Fourth-quarter 2027 – Thursday, January 13, 2...

WAKEFIELD, Mass.--(BUSINESS WIRE)--Franklin Street Properties Corp. (the “Company”, “FSP”, “we” or “our”) (NYSE American: FSP), a real estate investment trust (REIT), announced its results for the third quarter ended September 30, 2026. George J. Carter, Chairman and Chief Executive Officer, commented as follows: “As we continue to move through 2026, our focus remains squarely on trying to maximize shareholder value through our expanded evaluation of strategic alternatives, proactive asset mana...

SAN MATEO, Calif.--(BUSINESS WIRE)--Essex Property Trust, Inc. (NYSE: ESS) (the “Company”) announced today its third quarter 2026 earnings results and related business activities. Net Income, Funds from Operations (“FFO”), and Core FFO per diluted share for the three and nine-month periods ended September 30, 2026 are detailed below.   Three Months Ended September 30,   Nine Months Ended September 30,     % %   2026 2025 Change 2026 2025 Change Per Diluted Share             Net Income $1.52 $2....

LOS ANGELES e SAN DIEGO--(BUSINESS WIRE)--Pythia Labs, azienda biotecnologica che sviluppa modelli per l'IA di frontiera per la scoperta terapeutica, oggi ha annunciato il suo lancio assieme alla versione preprint pubblicata nell'archivio bioRxiv con cui ha presentato Pythia-1, il modello generativo a livello atomico che costituisce il fulcro della sua piattaforma di progettazione di anticorpi. La tecnologia di Pythia è stata sviluppata per creare anticorpi contro bersagli che hanno rappresenta...

LOS ÁNGELES y SAN DIEGO--(BUSINESS WIRE)--Pythia Labs, una empresa de biotecnología que desarrolla modelos de IA de frontera para el descubrimiento de terapias, anunció hoy su lanzamiento junto con un artículo preliminar en bioRxiv donde presenta Pythia-1, el modelo generativo de átomos completos que representa el núcleo de su plataforma de diseño de anticuerpos. La tecnología de Pythia está diseñada para crear anticuerpos contra dianas que han resultado difíciles de abordar con métodos convenc...

LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--Pythia Labs, een biotechnologiebedrijf dat frontier AI-modellen voor therapeutische ontdekking samenstelt, kondigde vandaag de lancering aan, samen met een preprint in bioRxiv ter introductie van Pythia-1, het generatieve 'all-atom'-model dat centraal staat in zijn platform voor ontwerp van antilichamen. Pythia’s technologie is ontwikkeld om antilichamen te creëren tegen targets die voor conventioneel ontdekken een uitdaging bleken, waaronder multi-pass...